We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Apply for a Temporary Work - Creative Worker visa to work in the UK in the creative industry - eligibility, extend, bring your family.
You must apply for a Temporary Work - Creative Worker visa if: you’ve been…
You need all of the following to be eligible for the creative category:…
When you apply, you’ll need to provide: your certificate of sponsorship…
Read the full guidance before you apply. Apply from outside the UK You…
Your partner and children can also apply to join you or stay in the UK as…
You can apply to extend your Temporary Work - Creative Worker visa. You…
You can enter the UK without applying for a visa in advance if you: have a…
This page includes summary of the winning bid for the UK & Republic of Korea (ROK) Open RAN R&D collaboration competition.
The Innovative Licensing and Access Pathway (ILAP) is focused on getting the most transformative new medicines to patients in the UK health system more quickly.
It is the only example globally of an end-to-end access pathway, where a medicine developer can work collaboratively with the national health system, the regulator, and health technology assessment bodies from the early stages of clinical development.
Cobalt Light Systems Ltd, a spinout from STFC, developed patented technology to identify materials through barriers.
Seven new CERSIs came together to showcase how partnerships will modernise regulation in AI, clinical trials, and advanced therapies, bringing innovations to patients sooner.
As part of Dstl's commitment to improving access to technologies, we're making some of our intellectual property (IP) available for free.
A speech by Jessica Lennard, CMA Chief Strategy & External Affairs Officer
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).